CAS: 349085-38-7 - 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropurin-7-yl)acetate
![1,2,3,6-Tetrahydro-1,3-dimethyl-N-[4-(1-methylethyl)phenyl]-2,6-dioxo-7H-purine-7-acetamide](https://static.cymitquimica.com/products/IN/thumb/DA0037ND.jpg)
1,2,3,6-Tetrahydro-1,3-dimethyl-N-[4-(1-methylethyl)phenyl]-2,6-dioxo-7H-purine-7-acetamide
CAS:349085-38-7
Formula:
C18H21N5O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
355.3910
Ref: IN-DA0037ND
| 1g | To inquire | ||
| 10mg | 55.00 € | ||
| 50mg | 175.00 € | ||
| 100mg | 203.00 € | ||
| 250mg | 508.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
HC-030031
CAS:349085-38-7
HC-030031 (TOSLAB 829227) is a potent TRPA1 inhibitor, which antagonizes AITC- and formalin-evoked calcium influx …
Formula:
C18H21N5O3
Purity:
99.69% - ≥95%
Color and Shape:
Solid
Molecular weight:
355.39
Ref: TM-T6530
| 10mg | 50.00 € | ||
| 50mg | 94.00 € | ||
| 100mg | 143.00 € | ||
| 200mg | 182.00 € | ||
| 1mL*10mM (DMSO) | 53.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
2-(1,3-DIMETHYL-2,6-DIOXOPURIN-7-YL)-N-(4-PROPAN-2-YLPHENYL)ACETAMIDE
CAS:349085-38-7
Purity:
98.0%
Molecular weight:
355.39801025390625
Ref: 10-F533420
| 1g | To inquire | ||
| 10mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Thursday 30 Jan 2025
HC 030031
Controlled ProductCAS:349085-38-7
Inhibits AITC- and formalin-induced calcium influx via TRPA1 channel
Formula:
C18H21N5O3
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
355.39 g/mol
Ref: 3D-FH23741
| 50mg | 485.00 € |
Estimated delivery in United States, on Friday 31 Jan 2025
HC 030031
Controlled ProductCAS:349085-38-7
Applications A TRPA1 (transient receptor potential) selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity. Not …
Formula:
C18H21N5O3
Color and Shape:
Neat
Molecular weight:
355.39
Ref: TR-H115000
| 10mg | 96.00 € | ||
| 500mg | 406.00 € |
Estimated delivery in United States, on Tuesday 4 Mar 2025
